Skip to main content

FDA Staff Don’t Take Position on Moderna COVID-19 Booster

Food and Drug Administration staffers in an unusual move didn’t take a stance on Moderna Inc.’s MRNA +0.72% application for a booster dose, indicating there may not be sufficient data to support the extra dose.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.